Request Deal Involvement

Nurix Therapeutics completed the $120m funding round.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Wilson Sonsini Goodrich & Rosati

legal advisors

Wilson Sonsini Goodrich & Rosati

Precision AQ

pr advisors

Precision AQ

or

Principals

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

ECOR1 CAPITAL

bidder

ECOR1 CAPITAL

REDMILE GROUP

bidder

REDMILE GROUP

NURIX THERAPEUTICS

target

NURIX THERAPEUTICS

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

THIRD ROCK VENTURES LLC

bidder

THIRD ROCK VENTURES LLC

THE COLUMN GROUP

bidder

THE COLUMN GROUP

BOXER CAPITAL

bidder

BOXER CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Nurix Therapeutics completed the $120m funding round.